Insulin Resistance  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00771004 / 2006-002237-20: Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.

Checkmark P2 data
Mar 2012 - Mar 2012: P2 data
Completed
2
63
Europe
Pioglitazone, ACTOS®, AD4833, Placebo
Takeda
Oxidative Stress, Coronary Artery Disease, Type 2 Diabetes
02/09
02/09
NCT00443755: Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

Completed
2
28
US
metformin, Fortamet, Glucophage, Glucophage Extended Release (XR), Glumetza, Riomet, pioglitazone, Actos, Placebo
Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Takeda Pharmaceuticals North America, Inc., National Center for Research Resources (NCRR)
Type 2 Diabetes, Insulin Resistance, Metabolic Syndrome
08/10
08/10
NCT00671515: Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

Completed
2
23
US
Pioglitazone, Actos
Joseph Calabrese, MD, Takeda Pharmaceuticals North America, Inc.
Depressive Disorder, Major, Metabolic Syndrome X
08/11
11/11
NCT00782795: Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality

Completed
2
64
US
Pioglitazone, Actos, Placebo
University of Michigan, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Takeda Pharmaceuticals North America, Inc.
Chronic Pancreatitis, Insulin Resistance, Normal or Mildly Abnormal Stool Fat Levels
12/13
12/13

Download Options